Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 168

1.

α-Linolenic acid is associated with MRI activity in a prospective cohort of multiple sclerosis patients.

Bjornevik K, Myhr KM, Beiske A, Bjerve KS, Holmøy T, Hovdal H, Midgard R, Riise T, Wergeland S, Torkildsen Ø.

Mult Scler. 2018 May 1:1352458518779925. doi: 10.1177/1352458518779925. [Epub ahead of print]

PMID:
29862891
2.

Discovering New Benefits From Old Drugs With Big Data-Promise for Parkinson Disease.

Olsen AL, Riise T, Scherzer CR.

JAMA Neurol. 2018 Apr 23. doi: 10.1001/jamaneurol.2018.0345. [Epub ahead of print] No abstract available.

PMID:
29710184
3.

Urate and the risk of Parkinson's disease in men and women.

Cortese M, Riise T, Engeland A, Ascherio A, Bjørnevik K.

Parkinsonism Relat Disord. 2018 Mar 28. pii: S1353-8020(18)30141-X. doi: 10.1016/j.parkreldis.2018.03.026. [Epub ahead of print]

PMID:
29615298
4.

Diabetes is associated with decreased migraine risk: A nationwide cohort study.

Antonazzo IC, Riise T, Cortese M, Berge LI, Engeland A, Bernt Fasmer O, Lund A, Joachim Ødegaard K, Poluzzi E, Bjornevik K.

Cephalalgia. 2017 Jan 1:333102417748573. doi: 10.1177/0333102417748573. [Epub ahead of print]

PMID:
29249165
5.

β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson's disease.

Mittal S, Bjørnevik K, Im DS, Flierl A, Dong X, Locascio JJ, Abo KM, Long E, Jin M, Xu B, Xiang YK, Rochet JC, Engeland A, Rizzu P, Heutink P, Bartels T, Selkoe DJ, Caldarone BJ, Glicksman MA, Khurana V, Schüle B, Park DS, Riise T, Scherzer CR.

Science. 2017 Sep 1;357(6354):891-898. doi: 10.1126/science.aaf3934.

PMID:
28860381
6.

Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping.

Antonazzo IC, Raschi E, Vignatelli L, Baldin E, Riise T, D'Alessandro R, De Ponti F, Poluzzi E.

Drug Saf. 2017 Sep;40(9):823-834. doi: 10.1007/s40264-017-0551-0.

PMID:
28597251
7.

Body size and physical exercise, and the risk of multiple sclerosis.

Cortese M, Riise T, Bjørnevik K, Myhr KM; Multiple Sclerosis Conscript Service Database Study Group.

Mult Scler. 2018 Mar;24(3):270-278. doi: 10.1177/1352458517699289. Epub 2017 Mar 13.

PMID:
28287051
8.

Physical activity is associated with a decreased multiple sclerosis risk: The EnvIMS study.

Wesnes K, Myhr KM, Riise T, Cortese M, Pugliatti M, Boström I, Landtblom AM, Wolfson C, Bjørnevik K.

Mult Scler. 2018 Feb;24(2):150-157. doi: 10.1177/1352458517694088. Epub 2017 Feb 1.

PMID:
28273774
9.

Negative interaction between smoking and EBV in the risk of multiple sclerosis: The EnvIMS study.

Bjørnevik K, Riise T, Bostrom I, Casetta I, Cortese M, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Magalhaes S, Pugliatti M, Wolfson C, Myhr KM.

Mult Scler. 2017 Jun;23(7):1018-1024. doi: 10.1177/1352458516671028. Epub 2016 Sep 23.

PMID:
27663872
10.

Preclinical disease activity in multiple sclerosis: A prospective study of cognitive performance prior to first symptom.

Cortese M, Riise T, Bjørnevik K, Bhan A, Farbu E, Grytten N, Hogenesch I, Midgard R, Smith Simonsen C, Telstad W, Ascherio A, Myhr KM.

Ann Neurol. 2016 Oct;80(4):616-24. doi: 10.1002/ana.24769.

PMID:
27554176
11.

Bakers' exposure to flour dust.

Kirkeleit J, Hollund BE, Riise T, Eduard W, Bråtveit M, Storaas T.

J Occup Environ Hyg. 2017 Feb;14(2):81-91.

PMID:
27540715
12.

Level of education and multiple sclerosis risk over a 50-year period: Registry-based sibling study.

Bjørnevik K, Riise T, Benjaminsen E, Celius EG, Dahl OP, Kampman MT, Løken-Amsrud KI, Midgard R, Myhr KM, Torkildsen Ø, Vatne A, Grytten N.

Mult Scler. 2017 Feb;23(2):213-219. doi: 10.1177/1352458516646863. Epub 2016 Jul 11.

13.

Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients.

Wergeland S, Myhr KM, Løken-Amsrud KI, Beiske AG, Bjerve KS, Hovdal H, Midgard R, Kvistad SS, Holmøy T, Riise T, Torkildsen Ø.

Eur J Neurol. 2016 Jun;23(6):1064-70. doi: 10.1111/ene.12986. Epub 2016 Mar 21.

PMID:
26998820
14.

Multiple sclerosis: A lifestyle disease?

Grant WB, Riise T.

Neurology. 2016 Mar 9. pii: 10.1212/WNL.0000000000002487. [Epub ahead of print] No abstract available.

PMID:
26962071
15.

Does low socioeconomic status in early life protect against multiple sclerosis? A multinational, case-control study.

Goulden R, Riise T, Myhr KM, Pugliatti M, Wolfson C.

Eur J Neurol. 2016 Jan;23(1):168-74. doi: 10.1111/ene.12830. Epub 2015 Oct 16.

PMID:
26475404
16.
17.

Level of education and multiple sclerosis risk after adjustment for known risk factors: The EnvIMS study.

Bjørnevik K, Riise T, Cortese M, Holmøy T, Kampman MT, Magalhaes S, Myhr KM, Wolfson C, Pugliatti M.

Mult Scler. 2016 Jan;22(1):104-11. doi: 10.1177/1352458515579444. Epub 2015 May 26.

18.

Depression in persons with diabetes by age and antidiabetic treatment: a cross-sectional analysis with data from the Hordaland Health Study.

Berge LI, Riise T, Tell GS, Iversen MM, Østbye T, Lund A, Knudsen AK.

PLoS One. 2015 May 26;10(5):e0127161. doi: 10.1371/journal.pone.0127161. eCollection 2015.

19.

The EnvIMS Study: Design and Methodology of an International Case-Control Study of Environmental Risk Factors in Multiple Sclerosis.

Magalhaes S, Pugliatti M, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Lauer K, Myhr KM, Parpinel M, Pekmezovic T, Riise T, Wolfson D, Zhu B, Wolfson C.

Neuroepidemiology. 2015;44(3):173-81. doi: 10.1159/000381779. Epub 2015 May 7.

20.

Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study.

Cortese M, Riise T, Bjørnevik K, Holmøy T, Kampman MT, Magalhaes S, Pugliatti M, Wolfson C, Myhr KM.

Mult Scler. 2015 Dec;21(14):1856-64. doi: 10.1177/1352458515578770. Epub 2015 May 6.

Supplemental Content

Loading ...
Support Center